George J Weiner
University of Iowa
H-index: 68
North America-United States
Top articles of George J Weiner
Title | Journal | Author(s) | Publication Date |
|---|---|---|---|
T cell help in the tumor microenvironment enhances rituximab-mediated NK cell ADCC | Blood | Jyoti Arora Sabarish Ayyappan Chaobo Yin Brian J Smith Caitlin D Lemke-Miltner | 2024/3/11 |
The Lymphoma Epidemiology of Outcomes cohort study: Design, baseline characteristics, and early outcomes | American journal of hematology | James R Cerhan Matthew J Maurer Brian K Link Andrew L Feldman Thomas M Habermann | 2024/3 |
Development of Monoclonal Antibodies for the Treatment of Lymphoma: Setting the Stage | Precision Cancer Therapies vol 2‐Immunologic Approaches for the Treatment of Lymphoid Malignancies‐From Concept to Practice | George J Weiner | 2024/2/21 |
Differential infiltration of key immune cell populations across malignancies varying by immunogenic potential and likelihood of response to immunotherapy | Cancer Research | Ahmad A Tarhini Islam Eljilany Sam Coleman Dale J Hedges Martin McCarter | 2024/3/22 |
Analysis of clonal heterogeneity within paired primary and metastatic tumor samples of patients with solid tumors and implications for neoantigen-based personalized cancer vaccines | Cancer Research | Alyssa Obermayer Timothy Shaw Darwin Chang Joshua Davis Jamie K Teer | 2024/3/22 |
1125 In vitro characterization of cellular responses elicited by endosomal TLR agonists encapsulated in Qβ virus-like particles | MM Hasibuzzaman Briana Ibarra Ishrat Khan Caitlin D Lemke-Miltner George J Weiner | 2023/11/1 | |
The immune cell state atlas analysis predicts therapeutic benefits with immune checkpoint inhibitors | Cancer Research | Tingyi Li Vineeth Sukrithan Aakrosh Ratan Martin McCarter John Carpten | 2023/4/4 |
185 Global and local copy number aberration signatures as prognostic and immunotherapeutic predictors | Xuefeng Wang Tingyi Li Timothy I Shaw Sijie Yao Islam Eljilany | 2023/11/1 | |
A novel humanized mouse model for study of T cells and NK cells in the tumor microenvironment | Cancer Research | Jyoti Arora Caitlin D Lemke-Miltner George J Weiner | 2023/4/4 |
The T Cell Immunoscore as a Reference for Biomarker Development Utilizing Real-World Data from Patients with Advanced Malignancies Treated with Immune Checkpoint Inhibitors | Cancers | Islam Eljilany Payman Ghasemi Saghand James Chen Aakrosh Ratan Martin McCarter | 2023/10/10 |
151 Genetic heterogeneity between paired primary and metastatic solid tumors and implications for neoantigen-based personalized cancer vaccines | Timothy I Shaw Darwin Chang Alyssa Obermayer Jamie Teer Xiaoqing Yu | 2023/11/1 | |
A novel RNA aptamer-based assay for quantifying fractional occupancy of PD1 by PDL1 in formalin fixed biospecimens | Cancer Research | Suresh Veeramani Nanmeng Yu Xian Jin Xie Kristen Coleman George J Weiner | 2023/4/4 |
1122 Vidutolimod, an immunostimulatory virus-like particle, reduces proliferation but enhances the activation of tumor-specific T cells | Travis D Fischer Caitlin D Lemke-Miltner George J Weiner | 2023/11/1 | |
Correction: Distinct germline genetic susceptibility profiles identified for common non-Hodgkin lymphoma subtypes | Leukemia | Sonja I Berndt Joseph Vijai Yolanda Benavente Nicola J Camp Alexandra Nieters | 2023/10 |
887 In vivo evaluation of the role of T cell help in NK cell mediated ADCC | Jyoti Arora Caitlin D Lemke-Miltner George J Weiner | 2023/11/1 | |
Genetic heterogeneity between paired primary and metastatic solid tumors and implications for neoantigen-based personalized cancer vaccines. | Timothy I Shaw Darwin Chang Alyssa N Obermayer Dale Hedges Aik-choon Tan | 2023/6/1 | |
898 Demonstration of the utility of real-world progression-free survival (rwPFS) by application of an IFN-γ-related signature in a real-world cohort of patients with melanoma | Michael D Radmacher Phaedra Agius Oliver A Hampton David M McKean Daniel R Elgort | 2023/11/1 | |
Incorporating long non-coding RNA (lncRNA) into genome-wide biomarker screening for prognostic gene signatures of immunotherapy outcomes. | Xuefeng Wang Tingyi Li Vineeth Sukrithan Aakrosh Ratan Martin McCarter | 2023/6/1 | |
Abstract B002: Vidutolimod, an immunostimulatory virus-like particle, reduces proliferation but enhances the activation of tumor-specific T cells | Cancer Immunology Research | Travis D Fischer Caitlin Lemke-Miltner George J Weiner | 2023/12/1 |
1279 A novel graphical deep neural network learning approach utilizing molecular data for optimizing patient selection for treatment with immune checkpoint inhibitors: An ORIEN … | Issam El Naqa Payman Ghasemi Aik Choon Tan James Chen Aakrosh Ratan | 2022/11/1 |
Co-Authors
